Active, not recruitingNCT03136887

JOURNEY II XR Safety and Effectiveness PMCF

Studying Vasculitis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Smith & Nephew, Inc.
Intervention: JOURNEY II XR Total Knee System(device)
Enrollment: 176 target
Eligibility: 22-75 years · All sexes
Timeline: 2017 – 2029

Study locations (14)

Loma Linda University Dept. of Orthopaedic Surgery, Loma Linda, California, United States
Holy Cross Orthopedic Institute, Fort Lauderdale, Florida, United States
Castle Orthopaedics & Sports Medicine, S.C., Aurora, Illinois, United States
Midwest Orthopaedics at Rush, Chicago, Illinois, United States
Anne Arundel Medical Center, Annapolis, Maryland, United States
DeClaire LaMacchia Orthopaedic Institute, Rochester, Michigan, United States
Reno Orthopaedic Center, Reno, Nevada, United States
Mercer Bucks Orthopaedics, Hamilton, New Jersey, United States
NYU Hospital for Joint Diseases / NYU Langone Medical Center, New York, New York, United States
Hospital for Special Surgery, New York, New York, United States
Columbia University Center for Hip & Knee Replacement, New York, New York, United States
The Lindner Research Center at the Christ Hospital, Cincinnati, Ohio, United States
Oregon Health & Science University, Portland, Oregon, United States
Providence Regional Medical Center Everett, Everett, Washington, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03136887 on ClinicalTrials.gov

Other trials for Vasculitis

Additional recruiting or active studies for the same condition.

See all trials for Vasculitis →

← Back to all trials